These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. General pharmacological profile of the new cognition-enhancing agent nefiracetam. Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090 [TBL] [Abstract][Full Text] [Related]
5. [Behavioral changes induced by psychotropic substances in experimental animals]. Kreiskott H Arzneimittelforschung; 1974 Sep; 24(9):1294-7. PubMed ID: 4479795 [No Abstract] [Full Text] [Related]
6. [Histamine and brain]. Boissier JR Actual Pharmacol (Paris); 1971; 24():51-92. PubMed ID: 5150622 [No Abstract] [Full Text] [Related]
7. Ethopharmacology; a new way to analyse drug effects on behaviour. Dixon AK Triangle; 1982; 21(2-3):95-105. PubMed ID: 7164161 [No Abstract] [Full Text] [Related]
8. Pharmacological profile of a new psychotherapeutic agent: 4-p-fluorophenyl-5-N(N'-o-methoxyphenyl)piperazinoethyl-4-oxazolin-2-one (LR 511). Fregnan GB; Vidali M Pharmacology; 1977; 15(6):485-502. PubMed ID: 563604 [No Abstract] [Full Text] [Related]
9. [Effect of vasopressin on changes in the behavioral reactions of rats induced by psychotropic substances]. Titov SA; Usenko AB; Ashmarin IP Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(2):292-5. PubMed ID: 2750290 [TBL] [Abstract][Full Text] [Related]
10. 1-hydroxy-3-amino-pyrrolidone-2 (HA-966). I. Behaviour and motor effects. Bonta IL; De Vos CJ; Hillen FC Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):391-3. PubMed ID: 4984370 [No Abstract] [Full Text] [Related]
11. [The characteristics of the neuropsychotropic activity of bromantane in laboratory animals]. Morozov IS; Klimova NV; Karpova TD; Shestopalov SS Eksp Klin Farmakol; 1999; 62(2):3-6. PubMed ID: 10340117 [TBL] [Abstract][Full Text] [Related]
12. [Problems in transferring data from animals to man in behavioral teratology]. Pavlík A; Jelínek R; Benesová O Cas Lek Cesk; 1982 Sep; 121(37):1157-60. PubMed ID: 7139673 [No Abstract] [Full Text] [Related]
13. [Methodical problems of psychopharmacology presented using the example of antidepressive agents]. Hoffmeister F Arzneimittelforschung; 1969 May; 19(5):808-10. PubMed ID: 5819796 [No Abstract] [Full Text] [Related]
14. Behavioral effects of psychotherapeutic agents in rats chronically dosed with alpha-acetylmethadol. Maickel RP; Lambert CS; Braude MC; Zabik JE Commun Psychopharmacol; 1978; 2(1):45-50. PubMed ID: 26496 [No Abstract] [Full Text] [Related]
17. [Effect of aziprine on the central nervous system]. Ponomareva AG Farmakol Toksikol; 1969; 32(4):403-6. PubMed ID: 5357457 [No Abstract] [Full Text] [Related]
18. Psychotropic drug effects on the emotional state of cats in a social situation [proceedings]. Valdman AV; Kozlovskaya MM Act Nerv Super (Praha); 1977 Sep; 19(3):222-4. PubMed ID: 920095 [No Abstract] [Full Text] [Related]
19. Basic ethers of 2-anilinobenzothiazoles and 2-anilinobenzoxazoles as potential antidepressants. Sharpe CJ; Palmer PJ; Evans DE; Brown GR; King G; Shadbolt RS; Trigg RB; Ward RJ; Ashford A; Ross JW J Med Chem; 1972 May; 15(5):523-9. PubMed ID: 4624685 [No Abstract] [Full Text] [Related]
20. Pharmacological studies of new indole alkaloids, rugulovasine A and B hydrochloride. Nagaoka A; Kikuchi K; Nagawa Y Arzneimittelforschung; 1972 Jan; 22(1):137-42. PubMed ID: 5066988 [No Abstract] [Full Text] [Related] [Next] [New Search]